BlackRock Health Sciences Trust (BME) To Go Ex-Dividend on December 22nd

BlackRock Health Sciences Trust (NYSE:BME) declared a monthly dividend on Friday, December 12th. Shareholders of record on Monday, December 22nd will be paid a dividend of 0.2621 per share on Wednesday, December 31st. This represents a c) annualized dividend and a yield of 7.7%. The ex-dividend date of this dividend is Monday, December 22nd.

BlackRock Health Sciences Trust Trading Up 0.9%

Shares of BME traded up $0.37 during mid-day trading on Friday, reaching $41.09. The company had a trading volume of 56,535 shares, compared to its average volume of 48,661. The company’s 50 day simple moving average is $39.57 and its 200 day simple moving average is $37.52. BlackRock Health Sciences Trust has a 1-year low of $34.18 and a 1-year high of $41.72.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

Hedge funds have recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. raised its position in BlackRock Health Sciences Trust by 22.2% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock valued at $53,000 after purchasing an additional 257 shares during the last quarter. Comerica Bank raised its holdings in BlackRock Health Sciences Trust by 7.9% in the 1st quarter. Comerica Bank now owns 4,807 shares of the company’s stock valued at $186,000 after buying an additional 353 shares during the last quarter. Oppenheimer & Co. Inc. boosted its position in BlackRock Health Sciences Trust by 5.9% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock worth $250,000 after buying an additional 373 shares during the period. SOA Wealth Advisors LLC. boosted its position in BlackRock Health Sciences Trust by 20.3% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock worth $103,000 after buying an additional 469 shares during the period. Finally, Royal Bank of Canada grew its holdings in BlackRock Health Sciences Trust by 0.5% during the 1st quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after acquiring an additional 684 shares during the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.